- Home
- OABI vs PLBC Comparison
OABI vs PLBC Comparison
Compare OABI & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- PLBC
- Stock Information
- Founded
- OABI 2012
- PLBC 1980
- Country
- OABI United States
- PLBC United States
- Employees
- OABI N/A
- PLBC N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- PLBC Finance Companies
- Sector
- OABI Health Care
- PLBC Finance
- Exchange
- OABI Nasdaq
- PLBC Nasdaq
- Market Cap
- OABI 228.9M
- PLBC 236.7M
- IPO Year
- OABI N/A
- PLBC 2005
- Fundamental
- Price
- OABI $1.64
- PLBC $44.25
- Analyst Decision
- OABI Strong Buy
- PLBC Buy
- Analyst Count
- OABI 3
- PLBC 4
- Target Price
- OABI $6.67
- PLBC $57.00
- AVG Volume (30 Days)
- OABI 435.2K
- PLBC 11.9K
- Earning Date
- OABI 11-11-2025
- PLBC 10-15-2025
- Dividend Yield
- OABI N/A
- PLBC 2.78%
- EPS Growth
- OABI N/A
- PLBC 1.22
- EPS
- OABI N/A
- PLBC 4.86
- Revenue
- OABI $23,027,000.00
- PLBC $84,003,000.00
- Revenue This Year
- OABI N/A
- PLBC $22.16
- Revenue Next Year
- OABI $44.99
- PLBC $17.58
- P/E Ratio
- OABI N/A
- PLBC $8.90
- Revenue Growth
- OABI 6.05
- PLBC 6.85
- 52 Week Low
- OABI $1.22
- PLBC $37.69
- 52 Week High
- OABI $4.87
- PLBC $51.33
- Technical
- Relative Strength Index (RSI)
- OABI 45.25
- PLBC 52.87
- Support Level
- OABI $1.54
- PLBC $42.97
- Resistance Level
- OABI $1.68
- PLBC $46.59
- Average True Range (ATR)
- OABI 0.08
- PLBC 0.87
- MACD
- OABI 0.01
- PLBC -0.08
- Stochastic Oscillator
- OABI 62.79
- PLBC 34.40
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.